The Safety and Efficacy of Rapid Acting TI Insulin (Afrezza) Compared with Subcutaneous Insulin to Achieve Pregnancy-Specific Postprandial Targets among Patients with Gestational Diabetes
Skip Navigation Links.
Please be patient while the page loads...
Not Found
The requested URL
/ndocs/inhalegdm/ScriptResource.axd
was not found on this server.
© 2007 -2025 Jaeb Center for Health Research